| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2003 | EP0910246A4 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 07/02/2003 | EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
| 07/02/2003 | EP0894010B1 Denaturants for sympathomimetic amine salts |
| 07/02/2003 | EP0879282B1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/02/2003 | EP0841916B1 Endothelin receptor antagonists |
| 07/02/2003 | EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level |
| 07/02/2003 | EP0810879B1 Preparation and use of a specific gaba-aalpha5 receptor ligand for treatment of alzheimer's disease |
| 07/02/2003 | EP0801557B1 Liposome formulations of 5beta steroids |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | EP0781129B1 Pharmaceutical preparation containing metformin and a process for producing it |
| 07/02/2003 | EP0779810B1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 07/02/2003 | EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | EP0720479B1 Transdermal therapeutic system with acetylsalicylic acid as active substance |
| 07/02/2003 | EP0660714B1 Novel liposomal drug delivery systems |
| 07/02/2003 | EP0626864B1 Topical composition containing hyaluronic acid and nsaids |
| 07/02/2003 | EP0578780B1 Suppression of thromboxane levels by percutaneous administration of aspirin |
| 07/02/2003 | CN1427952A Docosahexaenoic acid as retinoid X receptor and uses thereof |
| 07/02/2003 | CN1427846A Uridine derivatives as antibiotics |
| 07/02/2003 | CN1427845A Cyclipostins, method for their production and use of same |
| 07/02/2003 | CN1427844A Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents |
| 07/02/2003 | CN1427841A Novel crystal form of 9-substituted hypoxanthine derivatives |
| 07/02/2003 | CN1427840A Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists |
| 07/02/2003 | CN1427839A Charged compounds comprising nucleic acid binding moiety and uses therefor |
| 07/02/2003 | CN1427838A Hydantoin-containing glucokinase activators |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427835A Stepwise Alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 07/02/2003 | CN1427833A Method for production of L-ascorbic acid by lactonisation of 2-keto-L-gulonic acid or 2-keto-L-gulonate esters |
| 07/02/2003 | CN1427830A Para-substituted phenylamide glucokinase activators |
| 07/02/2003 | CN1427829A Substituted phenylacetamides and their use as glucokinase activators |
| 07/02/2003 | CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/02/2003 | CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427824A Indole derivatives, process for preparation of same and use thereof |
| 07/02/2003 | CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 07/02/2003 | CN1427730A Medicinal aerosol formulation |
| 07/02/2003 | CN1427727A Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 07/02/2003 | CN1427722A Method for treatment or prevention of flavivirus infections using nucleoside analogues |
| 07/02/2003 | CN1427721A Peptide deformylase inhibitors |
| 07/02/2003 | CN1427720A Metabotropic glutamate receptor antagonists for treating tolerance and dependency |
| 07/02/2003 | CN1427719A Use of substituted acryloyl distamycin derivatives in treatment of tumors associated with high levels of glutathione |
| 07/02/2003 | CN1427718A Pharmaceutical compounds for treating COPD |
| 07/02/2003 | CN1427717A Hydrophilic/lipophilic polymeric matrix dosage for mulation |
| 07/02/2003 | CN1427716A Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof |
| 07/02/2003 | CN1427714A External skin preparations for suppressing sebum secretion |
| 07/02/2003 | CN1427008A Method of designing and selecting natural siRNA as gene medicine and medicine formulation |
| 07/02/2003 | CN1427003A Baicalein 8-position substituted methylamine like derivative and its preparation method |
| 07/02/2003 | CN1426786A Ointment made of Chinese medicinal herbs for treating bedsore difficult to cure |
| 07/02/2003 | CN1426783A Application of evodiamine in the preparation of medicine |
| 07/02/2003 | CN1426782A Tanshinone 11A used in preparing medicine for preventing and treating atherosclerosis |
| 07/02/2003 | CN1426781A Method for slowing-down of violence leaning of adolescaria stag and promoting antler growth |
| 07/02/2003 | CN1426780A Gel type slow release tablet for treating diabetes and its preparation method |
| 07/02/2003 | CN1113103C CO2 absorption indicator and reagent kit for diagnosing pyloric Helicobacterium |
| 07/02/2003 | CN1113102C Antitumer preparation |
| 07/02/2003 | CN1113064C Cis-substituted aminocyclopropane derivatives |
| 07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/02/2003 | CN1112933C Anti-fungal methods and materials |
| 07/02/2003 | CN1112930C P1, P4-dithio-P2,P3-monochloromethylene 5'5-diadenosine P4,P4-tetraphosphate as antithrombotic agent |
| 07/02/2003 | CN1112929C Slow-release pharmaceutical formulations containing mizolastin |
| 07/02/2003 | CN1112928C Use of CGMP-phosphodiesterase inhibitors to treat impotence |
| 07/02/2003 | CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound |
| 07/02/2003 | CN1112926C Composition comprising 5-[4-(2-(n-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/02/2003 | CN1112925C Neuroprotective agents |
| 07/02/2003 | CN1112924C Rapamycin formulation for TV injection |
| 07/02/2003 | CN1112923C Indazole carboxamides |
| 07/02/2003 | CN1112922C Use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one for producing pharmaceutical preparation intended for treatment of alcheimer's disease |
| 07/02/2003 | CN1112921C Compositions containing micronized nebivolol |
| 07/02/2003 | CN1112920C Aminotetralin derivative for therapy of cardiovascular diseases |
| 07/02/2003 | CN1112918C Ophthalmic composition with decreased viscosity |
| 07/02/2003 | CN1112916C Composition containing free kind sphingol alkali and ceramide and its usage |
| 07/02/2003 | CN1112911C Composition for making-up and/or skin and use thereof |
| 07/01/2003 | USRE38167 Weight reduction method for cats and other pets |
| 07/01/2003 | US6586749 Device and method for photoactivation |
| 07/01/2003 | US6586634 Reacting in solvent at elevated temperature mixture of enantiomers of cis-1-amino-2-indanol with (R,R)-tartaric acid and methanol, crystallizing optically enriched (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate |
| 07/01/2003 | US6586633 Antifungal agents |
| 07/01/2003 | US6586631 Acetoacetarylamide as solidified melt in form which can be used in industry and is easy to handle, which has water content between 3 and 15 percent by weight |
| 07/01/2003 | US6586623 Thiol-based NAALADase inhibitors |
| 07/01/2003 | US6586618 Amination 1,3-dihydoxynaphthalene, then blocking, iodination, alkylation, cyclization and deblocking to give (5-hydroxy-3-amino-1-(S)-(chloromethyl)-1,2-dihydro-3H-benz(e)indole), used as chemical intermediates of antitumor agents |
| 07/01/2003 | US6586611 Zinc-monocysteine complex and method of using zinc-cysteine complexes |
| 07/01/2003 | US6586608 Emulsification of calcium carbonate or acetate in fatty acids or esters, by mixing and heating, then cooling and recovering the remaining fluid of the mixtures; mineralization; dosage |
| 07/01/2003 | US6586596 Acetylcholine enhancers |
| 07/01/2003 | US6586594 Reacting 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl) ethanone and 6-(1-bromoethyl)-4-chloro-5-fluoropyrimidine in the presence of zinc, iodine, lewis acids, aprotic solvents and optionally lead to form sterospecific fungicides |
| 07/01/2003 | US6586591 Process for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 07/01/2003 | US6586582 Human GABA receptor proteins and polynucleotides encoding the same |
| 07/01/2003 | US6586569 Endometriosis-associated gene |
| 07/01/2003 | US6586478 Methods and compositions for improving sleep |
| 07/01/2003 | US6586476 Methods for the treatment of nephro-disorders using aminothiol compounds |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586473 Topical drug delivery composition and method |
| 07/01/2003 | US6586472 Treatment of rosacea using lipoic acid |
| 07/01/2003 | US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586469 Carbetapentane tannate and pyrilamine tannate are administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions |
| 07/01/2003 | US6586467 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 07/01/2003 | US6586462 ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 07/01/2003 | US6586459 Antithrombotic agents |
| 07/01/2003 | US6586458 Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| 07/01/2003 | US6586457 Administering to a mammal for inhibiting bone resorption a therapeutically effective amount of an EP4 receptor subtype antagonist which is a 1,2,4-triazole-3-one derivative |
| 07/01/2003 | US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide |
| 07/01/2003 | US6586455 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonists |